These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12522038)

  • 1. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.
    Christopherson JA; Munson EL; England DM; Croke CL; Remington MC; Molitor ML; DeCoster DJ; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):44-52. PubMed ID: 12522038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.
    Burchill MA; Nardelli DT; England DM; DeCoster DJ; Christopherson JA; Callister SM; Schell RF
    Infect Immun; 2003 Jun; 71(6):3437-42. PubMed ID: 12761128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
    Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
    Munson EL; DeCoster DJ; Nardelli DT; England DM; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):35-41. PubMed ID: 14715542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.
    Munson EL; Du Chateau BK; Jensen JR; Callister SM; DeCoster DJ; Schell RF
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1095-101. PubMed ID: 12204965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
    Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthritis is inhibited in Borrelia-primed and infected interleukin-17A-deficient mice after administration of anti-gamma-interferon, anti-tumor necrosis factor alpha and anti-interleukin-6 antibodies.
    Kuo J; Warner TF; Schell RF
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.
    Nardelli DT; Warner TF; Callister SM; Schell RF
    Clin Vaccine Immunol; 2006 Aug; 13(8):884-91. PubMed ID: 16893988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrelia-primed and -infected mice deficient of interleukin-17 develop arthritis after neutralization of gamma-interferon.
    Kuo J; Warner TF; Schell RF
    Pathog Dis; 2017 Mar; 75(2):. PubMed ID: 28175297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.
    Lim LC; England DM; DuChateau BK; Glowacki NJ; Creson JR; Lovrich SD; Callister SM; Jobe DA; Schell RF
    Infect Immun; 1994 Jul; 62(7):2825-33. PubMed ID: 8005672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.
    Nardelli DT; Cloute JP; Luk KH; Torrealba J; Warner TF; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):786-92. PubMed ID: 15939755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
    Amlong CA; Nardelli DT; Peterson SH; Warner TF; Callister SM; Schell RF
    Clin Vaccine Immunol; 2006 Feb; 13(2):289-96. PubMed ID: 16467340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.
    Peterson SH; Nardelli DT; Warner TF; Callister SM; Torrealba JR; Schell RF
    Clin Vaccine Immunol; 2007 May; 14(5):510-7. PubMed ID: 17360856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.
    Lim LC; England DM; Glowacki NJ; DuChateau BK; Schell RF
    Infect Immun; 1995 Dec; 63(12):4818-25. PubMed ID: 7591141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hamster and murine models of severe destructive Lyme arthritis.
    Munson E; Nardelli DT; Du Chateau BK; Callister SM; Schell RF
    Clin Dev Immunol; 2012; 2012():504215. PubMed ID: 22461836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arthritis is developed in Borrelia-primed and -infected mice deficient of interleukin-17.
    Kuo J; Warner TF; Munson EL; Nardelli DT; Schell RF
    Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27493062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.
    Lim LC; England DM; DuChateau BK; Glowacki NJ; Schell RF
    Infect Immun; 1995 Apr; 63(4):1400-8. PubMed ID: 7890402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.
    Du Chateau BK; England DM; Callister SM; Lim LC; Lovrich SD; Schell RF
    Infect Immun; 1996 Jul; 64(7):2540-7. PubMed ID: 8698477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of
    Hilliard KA; Brown CR
    J Immunol; 2019 Mar; 202(6):1798-1806. PubMed ID: 30700583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
    Munson EL; Nardelli DT; Luk KH; Remington MC; Callister SM; Schell RF
    Clin Vaccine Immunol; 2006 Jan; 13(1):19-25. PubMed ID: 16425995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.